Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.12 USD | -5.26% | -8.79% | -30.85% |
May. 10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
May. 07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.85% | 5.5M | |
+34.67% | 50.85B | |
+0.62% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.76% | 26.11B | |
-21.57% | 19.13B | |
+8.77% | 13.05B | |
+26.96% | 12.16B | |
+24.35% | 12.08B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Transcript : Leading BioSciences Inc, Seneca Biopharma, Inc. - M&A Call